A Study of Lonafarnib With or Without Ritonavir in Patients With HDV

NCT02968641 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped This study was initially planned to enroll patients in Mongolia. However, due to challenges in setting it up in Mongolia, this study was later determined not to be initiated.

Conditions

Interventions

Sponsor

Eiger BioPharmaceuticals